The Pharmaceutical Research and Manufacturers of America (PhRMA) have re-elected Amgen’s Kevin Sharer as Chairman. This didn’t come as a surprise to anyone at the meeting.
However, what interests me is that Sharer has been quietly bringing Amgen people in to PhRMA to “help out” on some high profile projects. Given the current state and players at PhRMA, I can only assume this is a vote of no confidence in the PhRMA staff.
